Also, while overweight children with NAFLD only showed very early signs of the disease, IL-6 and TNFα levels in plasma were both higher in children with NAFLD than in overweight controls, whereas CRP and active PAI-1 levels in plasma—both markedly higher than in normal-weight controls—did not differ between overweight groups. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.